Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Use Of a Quality Management System and Outcome After Hematopoietic Stem Cell Transplantation

Per T. Ljungman, MD, PhD, Ronald Brand, PhD, Eoin McGrath, van Biezen Anja, Anna Sureda, MD, Helen Baldomero, Christian Chabannon, MD, PhD, Jane F. Apperley, MBChB, FRCP, FRCPath, Alois Gratwohl, MD

Blood (2013) 122 (21): 2945.

https://doi.org/10.1182/blood.V122.21.2945.2945

Published: 2013

Journal Articles

Second Allogeneic Stem Cell Transplantation (AlloSCT) In Patients With Relapsed Lymphoma After First Allosct. A Retrospective Study Of The EBMT Lymphoma Working Party

Kristin Horstmann, Ariane Boumendil, PhD, Herve Finel, Jane F. Apperley, MBChB, FRCP, FRCPath, Fabio Ciceri, MD, Juergen Finke, MD, Achiel Van Hoof, Norbert Ifrah, MD, Slawomira Kyrcz-Krzemien, MD, Gustavo Milone, Ghulam J Mufti, FRCP, FRCPath, Elizabeth Naparstek, MD, Reuven Or, MD, Nigel H Russell, MD, Peter Dreger, MD

Blood (2013) 122 (21): 4632.

https://doi.org/10.1182/blood.V122.21.4632.4632

Published: 2013

Journal Articles

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Florent Malard, Nicolaus Kröger, Ian H Gabriel, Dr, Kai Hübel, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, Grzegorz Basak, MD, PhD, Kenneth W Douglas, MD, Catarina Geraldes, MD, Ozren Jaksic, MD, PhD, Zdenek Koristek, MD, PhD, Francesco Lanza, MD, Roberto M. Lemoli, MD, Gabor Mikala, MD, PhD, Dominik Selleslag, MD, Nina Worel, MD, Rafael F. Duarte, MD, PhD, Mohamad Mohty

Blood (2011) 118 (21): 1932.

https://doi.org/10.1182/blood.V118.21.1932.1932

Published: 2011

Journal Articles

Second Autologous Stem Cell Transplantation Is Effective Salvage Therapy for Relapsed Multiple Myeloma.

Aristeidis Chaidos, MD, PhD, Chrissy Giles, B.A.(Hons), Holger W Auner, Marco Bua, Jiri Pavlu, Ellena Smith, Edward Kanfer, MD, Donald MacDonald, Jane F. Apperley, MBChB, FRCP, FRCPath, Amin Rahemtulla, MBBS, PhD, FRCP

Blood (2009) 114 (22): 1229.

https://doi.org/10.1182/blood.V114.22.1229.1229

Published: 2009

Journal Articles

T-Cell and B-Cell Responses After Vaccination against Influenza Virus and Pneumococcus in Chronic Phase CML Patients Treated with Tyrosine Kinase Inhibitors.

Hugues de Lavallade, MD, MsC, Melanie Hart, PhD, Ian H Gabriel, Dr, Peter Kelleher, MD, PhD, Abdullah Alsuliman, PhD, Ahmad Khoder, MD, Dragana Milojkovic, MD, Letizia Foroni, Marco Bua, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, John M Goldman, DM, FCRP, David Marin, MD, Katayoun Rezvani, MD, PhD

Blood (2009) 114 (22): 2214.

https://doi.org/10.1182/blood.V114.22.2214.2214

Published: 2009

Journal Articles

BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML.

Alexandra Bazeos, David Marin, Gareth Gerrard, PhD, Richard Szydlo, Dragana Milojkovic, MD, Alistair Reid, Hugues de Lavallade, Jane F. Apperley, MBChB, FRCP, FRCPath, John M Goldman, DM, FCRP, FRCPath, Letizia Foroni, Jamshid Sorouri Khorashad, MD

Blood (2009) 114 (22): 3248.

https://doi.org/10.1182/blood.V114.22.3248.3248

Published: 2009

Journal Articles

Nilotinib in Chronic Myeloid Leukemia Patients in Accelerated Phase (CML-AP) with Imatinib Resistance or Intolerance: 2-Year Follow-up Results of a Phase 2 Study

Philipp D. le Coutre, MD, Francis Giles, MD, Andreas Hochhaus, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, Gert Ossenkoppele, MD, PhD, Ariful Haque, Neil J. Gallagher, MD, PhD, Michele Baccarani, MD, Jorge Cortes, MD, Hagop M Kantarjian

Blood (2008) 112 (11): 3229.

https://doi.org/10.1182/blood.V112.11.3229.3229

Published: 2008

Journal Articles

Common Submicroscopic Genomic Imbalances Accompany the Ph Chromosome at Diagnosis in Chronic Myeloid Leukemia

Jamshid S Khorashad, MD, Valeria A De Melo, Heike Fiegler, PhD, Gareth Gerrard, PhD, Dan Brudzevsky, PhD, David Marin, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, John M Goldman, DM, FRCP, FRCPath, Letizia Foroni, MD, PhD, FRCPath, Alistair G Reid, PhD

Blood (2008) 112 (11): 3113.

https://doi.org/10.1182/blood.V112.11.3113.3113

Published: 2008

Journal Articles

Incorporating Marrow Plasma Cell Infiltration at Diagnosis and Cytogenetic Features into Prognostic Scoring at Point of Autologous Stem Cell Transplantation for Multiple Myeloma

Matthias Klammer, MD, MRCP, FRCPath, Chrissy Giles, B.A.(Hons), Alistair G Reid, BSc, PhD, Fiona M Ross, DPhil, Richard M. Szydlo, Jiri Pavlu, MRCP., FRCPath, Jane F. Apperley, MBChB, FRCP, FRCPath, Amin Rahemtulla, MBBS, PhD, FRCP

Blood (2008) 112 (11): 3319.

https://doi.org/10.1182/blood.V112.11.3319.3319

Published: 2008

Journal Articles

WT1 and PRAME Expression in CML: Quantitation by Real-Time PCR and Correlation with BCR-ABL Expression Levels

Gareth Gerrard, PhD, Caroline Cloke, BSc, Ian H Gabriel, Dr, Katayoun Rezvani, MD, PhD, Jane F. Apperley, MBChB, FRCP, FRCPath, Letizia Foroni, MD, PhD, FRCPath

Blood (2008) 112 (11): 4225.

https://doi.org/10.1182/blood.V112.11.4225.4225

Published: 2008

Journal Articles

Epidemiological Study on Survival of Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) Patients with T315I Mutation. Final Analysis

Franck E Nicolini, MD, PhD, Giovanni Martinelli, Dong-Wook Kim, MD, PhD, Andreas Hochhaus, MD, Michael J. Mauro, MD, Jorge Cortes, MD, Charles Chuah, MBChB, MRCP, MD, Inge Dufva, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, Fumiharu Yagasaki, MD, Jay Pearson, PhD, Senaka Peter, MBA, Cesar Sanz Rodriguez, MD, Frank Giles, MD, John M Goldman, DM, FCRP, FRCPath, Wei Zhou, PhD

Blood (2008) 112 (11): 188.

https://doi.org/10.1182/blood.V112.11.188.188

Published: 2008

NARROW

Use Of a Quality Management System and Outcome After Hematopoietic Stem Cell Transplantation

Second Allogeneic Stem Cell Transplantation (AlloSCT) In Patients With Relapsed Lymphoma After First Allosct. A Retrospective Study Of The EBMT Lymphoma Working Party

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Second Autologous Stem Cell Transplantation Is Effective Salvage Therapy for Relapsed Multiple Myeloma.

T-Cell and B-Cell Responses After Vaccination against Influenza Virus and Pneumococcus in Chronic Phase CML Patients Treated with Tyrosine Kinase Inhibitors.

BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML.

Nilotinib in Chronic Myeloid Leukemia Patients in Accelerated Phase (CML-AP) with Imatinib Resistance or Intolerance: 2-Year Follow-up Results of a Phase 2 Study

Common Submicroscopic Genomic Imbalances Accompany the Ph Chromosome at Diagnosis in Chronic Myeloid Leukemia

Incorporating Marrow Plasma Cell Infiltration at Diagnosis and Cytogenetic Features into Prognostic Scoring at Point of Autologous Stem Cell Transplantation for Multiple Myeloma

WT1 and PRAME Expression in CML: Quantitation by Real-Time PCR and Correlation with BCR-ABL Expression Levels

Epidemiological Study on Survival of Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) Patients with T315I Mutation. Final Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only